Is there an increased risk of transmission of COVID-19 associated with the use of nebulizers? Do nebulizers aerosolize SARS-CoV-2 particles? [v2.0]
dc.contributor.author | National Health Library and Knowledge Service Evidence Team | |
dc.contributor.author | Leen, Brendan | |
dc.date.accessioned | 2021-02-24T09:42:13Z | |
dc.date.available | 2020-03-27T12:14:11Z | |
dc.date.available | 2021-02-24T09:42:13Z | |
dc.date.issued | 2021-02-23 | |
dc.identifier.uri | http://hdl.handle.net/10147/627401 | |
dc.description | Main Points 1. AGP-related pathogen transmission in the delivery of nebulized medications is not supported by evidence or plausible hypothesis. 2. During nebulization, the aerosol derives from a non-patient source and does not carry patient-derived viral particles. If a particle in the aerosol coalesces with a contaminated mucous membrane, it will cease to be airborne and will not be part of an aerosol. 3. One potential complication is that nebulization significantly increases fugitive aerosols in within 1 meter of the patient, and can provoke coughing or sneezing, raising the possibility that infectious bio-aerosols might be dispersed. 4. There are no known infection-related hazards to an uninfected patient or to a patient with COVID-19 that preclude the use of a nebulizer at home. Patients should adhere to standard precautions: social distancing; increased nebulizer hygiene; nebulizer treatment in areas of increased air circulation. 5. Hospitals and healthcare facilities should continue to adhere to stringent sanitization protocols and use of PPE in the presence of COVID-19 patients. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Service Executive | en_US |
dc.relation.ispartofseries | Evidence summaries | en_US |
dc.relation.ispartofseries | Question 15 | en_US |
dc.subject | CORONAVIRUS | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | AEROSOL GENERATING PROCEDURES | en_US |
dc.subject | NEBULISERS | en_US |
dc.subject | INFECTION PREVENTION AND CONTROL | en_US |
dc.title | Is there an increased risk of transmission of COVID-19 associated with the use of nebulizers? Do nebulizers aerosolize SARS-CoV-2 particles? [v2.0] | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2020-03-27T12:14:12Z |
Files in this item
This item appears in the following Collection(s)
-
HSE Library Summaries of Evidence
Evidence summaries and reviews on the management and treatment of Novel Coronavirus Covid-19 and other clinical topics